Suppr超能文献

原发性结直肠癌患者围手术期癌胚抗原比值、肿瘤部位与总生存期之间的关联

Association between Primary Perioperative CEA Ratio, Tumor Site, and Overall Survival in Patients with Colorectal Cancer.

作者信息

Odeny Thomas A, Farha Nicole, Hildebrandand Hannah, Allen Jessica, Vazquez Wilfred, Martinez Maximillian, Paluri Ravi Kumar, Kasi Anup

机构信息

Department of Medicine, University of Missouri-Kansas City, Kansas City, MO 64108, USA.

Department of Medicine, University of Kansas Medical School, Kansas City, KS 66160, USA.

出版信息

J Clin Med. 2020 Nov 27;9(12):3848. doi: 10.3390/jcm9123848.

Abstract

There are differences in the incidence, clinical presentation, molecular pathogenesis, and outcome of colorectal cancer (CRC) based on tumor location. Emerging research suggests that the perioperative carcinoembryonic antigen (CEA) ratio (post-op/pre-op CEA) is a prognostic factor for CRC patients. We aimed to determine the association between CEA ratio, tumor location, and overall survival (OS) among patients with CRC. We analyzed 427 patients who underwent resection for CRC at the University of Kansas Medical Center. After excluding those without pre- or post-operative CEA data, 207 patients were classified as either high (≥0.5) or low (<0.5) ratio. Primary outcomes were as follows: (1) OS stratified by CEA ratio; (2) OS stratified by tumor location; (3) OS stratified by tumor location among those with CEA elevation > 5 ng/mL at the time of recurrence. The Kaplan-Meier method was used to estimate survival rates. The median age was 62 years (inter-quartile range 51-71), 55% were male, 41% were smokers, 71% had left-sided tumors, the median pre-operative CEA was 3.1 ng/mL (inter-quartile range (IQR) 1.5-9.7), and 57% had a CEA ratio ≥0.5. The OS rates were 65.1% and 86.3% in patients with high versus low CEA ratios, respectively (log-rank -value = 0.045). The OS rates were 64.4% and 77.3% in patients with right-sided vs. left-sided tumors, respectively (log-rank -value = 0.5). Among patients with CEA levels greater than 5 at the time of recurrence, the OS rates were 42.9% and 43.4% in patients with right-sided vs. left-sided tumors, respectively (log-rank -value = 0.7). There was a significantly higher survival among patients with low CEA ratios than among those with high CEA ratios. There was no difference in OS between left- versus right-sided tumors. Among patients with CEA elevation > 5 ng/mL at the time of recurrence, there was no difference in OS between left versus right-sided tumors. These findings warrant validation in a larger cohort as our sample size was limited.

摘要

根据肿瘤位置的不同,结直肠癌(CRC)在发病率、临床表现、分子发病机制及预后方面存在差异。新出现的研究表明,围手术期癌胚抗原(CEA)比值(术后/术前CEA)是CRC患者的一个预后因素。我们旨在确定CRC患者中CEA比值、肿瘤位置与总生存期(OS)之间的关联。我们分析了在堪萨斯大学医学中心接受CRC切除术的427例患者。在排除那些没有术前或术后CEA数据的患者后,207例患者被分为高比值(≥0.5)或低比值(<0.5)。主要结局如下:(1)按CEA比值分层的OS;(2)按肿瘤位置分层的OS;(3)复发时CEA升高>5 ng/mL的患者中按肿瘤位置分层的OS。采用Kaplan-Meier法估计生存率。中位年龄为62岁(四分位间距51 - 71岁),55%为男性,41%为吸烟者,71%患有左侧肿瘤,术前CEA中位数为3.1 ng/mL(四分位间距(IQR)1.5 - 9.7),57%的患者CEA比值≥0.5。CEA比值高的患者与低的患者的OS率分别为65.1%和86.3%(对数秩检验P值 = 0.045)。右侧肿瘤患者与左侧肿瘤患者的OS率分别为64.4%和77.3%(对数秩检验P值 = 0.5)。在复发时CEA水平大于5的患者中,右侧肿瘤患者与左侧肿瘤患者的OS率分别为42.9%和43.4%(对数秩检验P值 = 0.7)。CEA比值低的患者的生存率显著高于CEA比值高的患者。左侧肿瘤与右侧肿瘤的OS无差异。在复发时CEA升高>5 ng/mL的患者中,左侧肿瘤与右侧肿瘤的OS无差异。由于我们的样本量有限,这些发现有待在更大的队列中进行验证。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8913/7760538/8f64fdfb919d/jcm-09-03848-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验